AACR Associate Member Council members offer advice for how graduate students can make the most of AACR resources for...
A look behind the scenes into the planning of the AACR Annual Meeting, including the scientific program, conference logistics,...
Heather K. Beasley was among the researchers who visited Washington, D.C to push for sustained NIH funding during AACR...
In the first quarter of 2026, the FDA issued nine approvals in oncology, including treatments for blood cancers, pancreatic...
The spring 2026 issue of Cancer Today included articles about using AI chatbots, cancer survivor—and “Survivor” winner—Ethan Zohn, and...
In March, AACR's journals editors highlighted studies on the development of pediatric leukemia, the use of low-dose tamoxifen, and...
In November 2025, AACR on Campus events were held in Taiwan where local early-career researchers engaged with global leaders...
Learn about smoldering myeloma and the first treatment approved by the U.S. Food and Drug Administration to prevent its...
AACR journals editors Robert Kruger and Elizabeth McKenna share how they're working to strengthen ties with the research...
Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
Epidemiologist Elizabeth A. Platz explains what goes into calculating cancer risk estimates, such as rate ratio, hazard ratio, and...